Bayesian Capital Management, LP Edwards Lifesciences Corp Transaction History

Bayesian Capital Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $467,013 - $692,529	-5,399 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $550,482 - $692,907	5,399 New	5,399 $636,000
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $1.62 Million - $1.87 Million	-20,600 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $616,534 - $784,578	-8,600 Reduced 29.45%	20,600 $1.88 Million
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $638,305 - $830,680	9,500 Added 48.22%	29,200 $2.33 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $955,164 - $1.28 Million	16,600 Added 535.48%	19,700 $1.36 Million
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $990,548 - $1.53 Million	-18,900 Reduced 85.91%	3,100 $585,000
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $1.37 Million - $1.57 Million	19,100 Added 658.62%	22,000 $5.13 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $178,495 - $218,747	2,900 New	2,900 $638,000
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $519,121 - $627,347	-12,229 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $454,796 - $580,266	12,229 New	12,229 $1.71 Million
Q4 2017 Feb 12, 2018	SELL	$33.79 - $39.39 $649,072 - $756,642	-19,209 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $697,094 - $745,885	19,209	19,209 $2.1 Million

1,349

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $43.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.